Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy

Primary central nervous system lymphoma (PCNSL) is a rare and aggressive disease that originates from lymphocytes and develops in the central nervous system. There is no standard consolidation/maintenance therapy for PCNSL. While there exists a variety of options, the high chance of inferior outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Steven, Bota, Daniela, Kong, Xiao-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326764/
https://www.ncbi.nlm.nih.gov/pubmed/35893281
http://dx.doi.org/10.3390/neurolint14030046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326764/
https://www.ncbi.nlm.nih.gov/pubmed/35893281
http://dx.doi.org/10.3390/neurolint14030046

Ejemplares similares